SARS-CoV-2: vaccines in the pandemic era
Abstract Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused millions of infections and deaths worldwide since its emergence in December 2019. As there is little or no natural immunity in the human population or specific anti-CO...
Main Authors: | Dan-Dan Li, Qi-Han Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-01-01
|
Series: | Military Medical Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40779-020-00296-y |
Similar Items
-
An Overview of Vaccines against SARS-CoV-2 in the COVID-19 Pandemic Era
by: Alejandro Pascual-Iglesias, et al.
Published: (2021-08-01) -
Developing dendritic cell for SARS-CoV-2 vaccine: Breakthrough in the pandemic
by: Jonny Jonny, et al.
Published: (2022-09-01) -
Platforms Exploited for SARS-CoV-2 Vaccine Development
by: Shilu Mathew, et al.
Published: (2020-12-01) -
SARS-CoV-2: An Analysis of the Vaccine Candidates Tested in Combatting and Eliminating the COVID-19 Virus
by: Laila Elmancy, et al.
Published: (2022-12-01) -
Coronavirus (SARS-CoV-2): a systematic review for potential vaccines
by: Mihir Bhatta, et al.
Published: (2022-01-01)